Brighton Jones’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
Brighton Jones's PTCT Position: Q3 2026 in Review
Brighton Jones sold out of PTC Therapeutics (PTCT) in Q3 2026, closing a stake of 3,148 shares — an estimated $257K sold.
Brighton Jones first reported a position in PTCT in Q2 2025 and held it in 2 quarters. The position peaked at $257K in Q2 2026. 302 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- Brighton Jones reported no remaining PTC Therapeutics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 3,148 PTC Therapeutics shares in Q3 2026, an estimated $257K.
- Brighton Jones first reported a position in PTC Therapeutics in Q2 2025 and held it in 2 quarters.
- Brighton Jones's PTC Therapeutics position peaked at $257K in Q2 2026.
- 302 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.